行情

TTOO

TTOO

T2 Biosystems
NASDAQ

实时行情|Nasdaq Last Sale

0.5250
-0.0095
-1.78%
盘后: 0.5331 +0.0081 +1.54% 18:19 04/07 EDT
开盘
0.5325
昨收
0.5345
最高
0.5380
最低
0.5153
成交量
333.41万
成交额
--
52周最高
3.280
52周最低
0.2350
市值
5,289.53万
市盈率(TTM)
-0.4040
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测TTOO价格均价为6.32,最高价位20.00,最低价为1.100。

EPS

TTOO 新闻

更多
  • Is the Options Market Predicting a Spike in T2 Biosystems (TTOO) Stock?
  • Zacks · 03/26 13:48
  • TWO, ARI, GOGO and TTOO among midday movers
  • Seeking Alpha - Article · 03/25 16:42
  • The Daily Biotech Pulse: T2 Biosystems Licenses COVID-19 Test, Immuron CEO Steps Down
  • Benzinga · 03/25 12:29
  • Covid-19-related activity - healthcare
  • Seeking Alpha - Article · 03/25 11:37

所属板块

先进医疗设备和技术
-1.01%
医疗设备和用品
-0.82%

热门股票

代码
价格
涨跌幅

TTOO 简况

T2 Biosystems, Inc. is an in vitro diagnostics company engaged in developing a technology platform offering an alternative to diagnostic methodologies. The Company's T2 Magnetic Resonance platform (T2MR) enables detection of pathogens, biomarkers and other abnormalities in a range of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as one colony forming unit per milliliter (CFU/mL). The Company's initial development efforts target sepsis, hemostasis and Lyme disease. T2MR is a miniaturized, magnetic resonance-based approach that measures how water molecules react in the presence of magnetic fields. Its platform detects a range of targets, including molecular targets, such as deoxyribonucleic acid (DNA), immunodiagnostics, such as proteins, and a range of hemostasis measurements. The Company offers T2Dx Instrument (T2Dx) and the T2Candida Panel.
展开

微牛提供T2 Biosystems Inc(NASDAQ-TTOO)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的TTOO股票新闻,以帮助您做出投资决策。